SCHEMBL30980723

SCHEMBL30980723

CC(=O)N[C@@H]1[C@@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H](COCc2ccccc2)O[C@@H]1c1ccn(CCOCCOCCNC(=O)OC(C)(C)C)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 2/20 0.45
▸ MDM2 Q00987 2/20 0.45
▸ MDM4 O15151 1/20 0.45
▸ HSP90AA1 P07900 1/20 0.45
▸ HSP90AB1 P08238 1/20 0.45
▸ PTPN1 P18031 10/20 0.43
▸ CDC25B P30305 9/20 0.43
▸ PTPN2 P17706 5/20 0.43
▸ CDC25A P30304 4/20 0.43
▸ PTPN6 P29350 1/20 0.43
▸ PTPN11 Q06124 1/20 0.43
▸ BCHE P06276 2/20 0.38
▸ CNR2 P34972 1/20 0.35
▸ HDAC3 O15379 1/20 0.34
▸ HDAC4 P56524 1/20 0.34
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC7 Q8WUI4 1/20 0.34
▸ HDAC2 Q92769 1/20 0.34
▸ HDAC10 Q969S8 1/20 0.34
▸ HDAC11 Q96DB2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30980693 0.83 PTPN1 (0.47) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL30980474 0.81 PTPN1 (0.47) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL30980528 0.78 TP53 (0.41) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL30980730 0.76 TP53 (0.56) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL30980750 0.74 PTPN1 (0.47) PTPN1CDC25BPTPN2CDC25APTPN6
SCHEMBL30980588 0.72 NT5E (0.49) PTPN1CDC25BPTPN2CDC25APTPN6
SCHEMBL13296098 0.71 TP53 (0.55) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL24997002 0.71 TACR1 (0.43) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL15514995 0.71 PTPN1 (0.55) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL12612570 0.70 PTPN1 (0.50) TP53MDM2MDM4HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4651902-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 — — EP disclosed
EP-4651901-A1 CYCLING LYSOSOMAL TARGETING ANTIBODY CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 — — EP disclosed
WO-2024155747-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES LYCIA THERAPEUTICS, INC. (US) 2024-07-25 — — WO disclosed
Send feedback